Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer
Urothelial carcinoma of the bladder is characterized by significant variability in clinical outcomes depending on stage and grade. The addition of molecular information may improve our understanding of such heterogeneity and enhance prognostic prediction. The purpose of this study was to validate and improve published prognostic signatures for high-risk bladder cancer.
Cancer Type: Bladder Cancer
GPL: 570
Number of Genes with Data: 978
Number Observations: 93
Number Outputs: 2
Imbalanced Ratio: 0.710526316
Default Task: Classification